Association of polymorphisms in interleukin-18 and interleukin-28b with hepatitis b recurrence after liver transplantation in chinese han population

International Journal of Immunogenetics

Volumn 39, Issue 4, 2012, Pages 346-352

  Li, Y ^a   Shi, Y ^a   Chen, J ^a   Cai, B ^a   Ying, B ^a   Wang, L ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; HEPATITIS B ANTIBODY; INTERLEUKIN 18; INTERLEUKIN 28B; LAMIVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHINESE; CONTROLLED STUDY; END STAGE LIVER DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HUMAN; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALANINE TRANSAMINASE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; CHINA; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-18; INTERLEUKINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECURRENCE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84863574241     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2012.01097.x     Document Type: Article

References (27)

1. Arimitsu, J., Hirano, T., Higa, S., Kawai, M., Naka, T., Ogata, A. et al. (2006) IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochemical and Biophysical Research Communications, 342, 1413.
2. Asselah, T. (2010) Genetic polymorphism and response to treatment in chronic hepatitis C: the future of personalized medicine. Journal of Hepatology, 52, 452.
3. Chen, D.Y., Hsieh, C.W., Chen, K.S., Chen, Y.M., Lin, F.J. & Lan, J.L. (2009) Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus, 18, 29.
4. Giedraitis, V., He, B., Huang, W.X. & Hillert, J. (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. Journal of Neuroimmunology, 112, 146.
5. Guidotti, L.G., Ishikawa, T., Hobbs, M.V., Matzke, B., Schreiber, R. & Chisari, F.V. (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity, 4, 25.
6. Jiang, L., Jiang, L.S., Cheng, N.S. & Yan, L.N. (2009) Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World Journal of Gastroenterology, 15, 2489.
7. Jiang, L., Yan, L., Li, B., Wen, T., Zhao, J., Jiang, L. et al. (2010) Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. American Journal of Transplantation, 10, 1861.
8. Khripko, O.P., Sennikova, N.S., Lopatnikova, J.A., Khripko, J.I., Filipenko, M.L., Khrapov, E.A., Gelfgat, E.L., Yakushenko, E.V., Kozlov, V.A. & Sennikov, S.V. (2008) Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediators of Inflammation, 2008, 1.
9. Kimura, K., Kakimi, K., Wieland, S., Guidotti, L.G. & Chisari, F.V. (2002) Interleukin-18 inhibits Hepatitis B virus replication in the livers of transgenic mice. Journal of Virology, 76, 10702.
10. Kotenko, S.V., Gallagher, G., Baurin, W., Lewis-Antes, A., Shen, M., Shah, N.K., Langer, J.A., Sheikh, F., Dickensheets, H. & Donnelly, R.P. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunology, 4, 69.
11. Li, M., Liu, X., Zhou, Y. & Su, S.B. (2009) Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. Journal of Leukocyte Biology, 86, 23.
12. Li, W., Jiang, Y., Jin, Q., Shi, X., Jin, J., Gao, Y., Pan, Y., Zhang, H., Jiang, J. & Niu, J. (2011) Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver International, 31, 1118.
13. Lin, M.C., Lee, N.P., Zheng, N., Yang, P.H., Wong, O.G. et al. (2005) Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus. World Journal of Gastroenterology, 11, 7564.
14. Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annual Review of Immunology, 19, 423.
15. Pan, T., Cai, M., Tang, L., Zhou, L.Q., Li, B.J., Zhu, T. et al. (2008) A novel approach of prophylaxis to HBV recurrence after liver transplantation. Virology, 382, 1.
16. Rauch, A., Kutalik, Z., Descombes, P., Cai, T., Di Iulio, J., Mueller, T. et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology, 138, 1338.
17. Robek, M.D., Boyd, B.S. & Chisari, F.V. (2005) Lambda interferon inhibits hepatitis B and C virus replication. Journal of Virology, 79, 3851.
18. Romero, R. & Lavine, J.E. (1996) Cytokine inhibition of the hepatitis B virus core promoter. Hepatology, 23, 17.
19. Sun, Y., Chen, H.Y. & Xin, S.J. (2004) Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines. Hepatobiliary & Pancreatic Diseases International, 3, 230.
20. Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M. & Abate, M.L. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics, 41, 1100.
21. Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N. et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nature Genetics, 41, 1105.
22. Tanaka-Kataoka, M., Kunikata, T., Takayama, S., Iwaki, K., Ohashi, K., Ikeda, M. & Kurimoto, M. (1999) In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine, 11, 593.
23. Xie, S.B., Zhu, J.Y., Ying, Z., Zeng, L.J., Chao, M. & Lu, M.Q. (2010) Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study. Transplantation, 90, 786.
24. Xu, X., Tu, Z., Wang, B., Ling, Q., Zhang, L., Zhou, L., Jiang, G., Wu, J. & Zheng, S. (2011) A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation. Liver International, 31, 1477.
25. Zhang, P.A., Wu, J.M., Li, Y. & Yang, X.S. (2005) Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World Journal of Gastroenterology, 11, 1594.
26. Zhang, J., Zhou, L. & Zheng, S.S. (2010) Clinical management of hepatitis B virus infection correlated with liver transplantation. Hepatobiliary & Pancreatic Diseases International, 9, 15.
27. Zhao, J., Yan, L., Li, B., Zeng, Y., Wen, T., Zhao, J. et al. (2009) Diabetes mellitus after living donor liver transplantation: data from mainland China. Transplantation Proceedings, 41, 1756.